source
- Catalent to sell its Nottingham oral solid dose facility to CDMO CodisCatalent announced it will divest its United Kingdom manufacturing site, selling the oral solid dose factory located in Nottingham. The buyer is Codis, a contract development and manufacturing org…
- Updated: AstraZeneca sinks on unexpected heart drug trial failureAstraZeneca’s shares dropped in early trading Thursday after a heart disease treatment it is developing with Ionis Pharmaceuticals surprisingly failed in a late-stage trial. The companies had aimed…Endpoints · 1mo ago↗ source